SGO Annual Meeting on Women’s Cancer: What to Expect
Preview key themes and trends that will be presented during the Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer.
All articles by Cancer Therapy Advisor Staff
Pilot Study Seeks to Assess Physical Activity Program in Patients With Gastrointestinal Cancer
Researchers are seeking to assess a physical activity program program in patients with gastrointestinal cancer.
Early Phase 1 Trial Investigating Postoperative Treatment Selection After Preoperative Chemotherapy for Gastric Cancers
Researchers are seeking to determine the feasibility of receiving either postoperative chemoradiation or chemotherapy, based on nodal status at surgery.
Phase 1, 2 Trials to Assess Imaging System for Gastrointestinal Cancer Detection
Researchers are seeking to assess the initial safety and efficacy of LUM015 imaging of colorectal, pancreatic, and esophageal cancers using the LUM 2.6 imaging device.
2018 San Antonio Breast Cancer Symposium: What to Expect
The San Antonio Breast Cancer Symposium will take place from December 4-8 at the Henry B. Gonzalez Convention Center in Texas.
Phase 1/2 Trial of CAR-T Cell Immunotherapy in Metastatic, Mesothelin-Expressing Cancer
Researchers are evaluating whether CAR-T cell immunotherapy that targets mesothelin is safe and effective among patients with mesothelin-expressing tumors.
Randomized Trial of Stepped vs Early Integrated Palliative Care for Lung Cancer
Researchers are evaluating whether early integrated palliative care yields superior quality of life outcomes to stepped palliative care.
Phase 2 Study of Chemoradiotherapy Alone or With Surgery for Esophageal and Gastric Cancer
Researchers are evaluating the safety and efficacy of additional chemotherapy and radiation, alone or with surgery, among patients with esophageal or gastric cancer.
Phase 2 Study of Surgical Resection and HIPEC for Gastric Cancer
Researchers are investigating the efficacy of surgical resection plus HIPEC for improving survival outcomes among patients with gastric cancer.
Phase 3 Study of FOLFIRI Alone or With Napabucasin for Metastatic Colorectal Cancer
Researchers are evaluating the efficacy of FOLFIRI plus napabucasin with that of FOLFIRI alone in patients with colorectal cancer.
Next post in Gastrointestinal Cancers
